Robert Stockton Jones Jr.

Array ( [id] => 5881537 [patent_doc_number] => 20060030620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Method for treating and/or preventing ischemia/reperfusion injury' [patent_app_type] => utility [patent_app_number] => 10/910295 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3684 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030620.pdf [firstpage_image] =>[orig_patent_app_number] => 10910295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434618 [patent_doc_number] => 20040266722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => '4\'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication' [patent_app_type] => new [patent_app_number] => 10/891967 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10955 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266722.pdf [firstpage_image] =>[orig_patent_app_number] => 10891967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7249921 [patent_doc_number] => 20040258728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents' [patent_app_type] => new [patent_app_number] => 10/874384 [patent_app_country] => US [patent_app_date] => 2004-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3884 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258728.pdf [firstpage_image] =>[orig_patent_app_number] => 10874384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7316649 [patent_doc_number] => 20040223922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Clear micellized formulations of beta-carotene and method of treating leukoplakia' [patent_app_type] => new [patent_app_number] => 10/869124 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3992 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20040223922.pdf [firstpage_image] =>[orig_patent_app_number] => 10869124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297659 [patent_doc_number] => 20040214877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors' [patent_app_type] => new [patent_app_number] => 10/854954 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1081 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214877.pdf [firstpage_image] =>[orig_patent_app_number] => 10854954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939813 [patent_doc_number] => 20050113376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury' [patent_app_type] => utility [patent_app_number] => 10/854648 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25077 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113376.pdf [firstpage_image] =>[orig_patent_app_number] => 10854648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 843732 [patent_doc_number] => 07388030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-17 [patent_title] => 'Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite' [patent_app_type] => utility [patent_app_number] => 10/851338 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8029 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/388/07388030.pdf [firstpage_image] =>[orig_patent_app_number] => 10851338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089780 [patent_doc_number] => 20050009893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Treatment of high blood pressure during the acute phase of a stroke' [patent_app_type] => utility [patent_app_number] => 10/851660 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1394 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009893.pdf [firstpage_image] =>[orig_patent_app_number] => 10851660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378407 [patent_doc_number] => 20040220188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Alkylidene pyrazolidinedione derivatives' [patent_app_type] => new [patent_app_number] => 10/481240 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26204 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220188.pdf [firstpage_image] =>[orig_patent_app_number] => 10481240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378368 [patent_doc_number] => 20040220184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)' [patent_app_type] => new [patent_app_number] => 10/851826 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11121 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220184.pdf [firstpage_image] =>[orig_patent_app_number] => 10851826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297517 [patent_doc_number] => 20040214845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Barbiturates as integrin antagonists and their use for treating inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/848718 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6057 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214845.pdf [firstpage_image] =>[orig_patent_app_number] => 10848718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939870 [patent_doc_number] => 20050113433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/845009 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15041 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113433.pdf [firstpage_image] =>[orig_patent_app_number] => 10845009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435962 [patent_doc_number] => 07262219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy' [patent_app_type] => utility [patent_app_number] => 10/841709 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28657 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262219.pdf [firstpage_image] =>[orig_patent_app_number] => 10841709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434448 [patent_doc_number] => 20040209952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Composition containing chalcone' [patent_app_type] => new [patent_app_number] => 10/838853 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6137 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209952.pdf [firstpage_image] =>[orig_patent_app_number] => 10838853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7352068 [patent_doc_number] => 20040248928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Pharmaceutical composition comprising an adenosine A1/A2 agonist and a sodium hydrogen exchanger inhibitor' [patent_app_type] => new [patent_app_number] => 10/835964 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8012 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248928.pdf [firstpage_image] =>[orig_patent_app_number] => 10835964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 577975 [patent_doc_number] => 07456179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Methods of treating ischemic related conditions' [patent_app_type] => utility [patent_app_number] => 10/835668 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11898 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456179.pdf [firstpage_image] =>[orig_patent_app_number] => 10835668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330095 [patent_doc_number] => 20040254208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Compositions for affecting weight loss' [patent_app_type] => new [patent_app_number] => 10/828795 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14960 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254208.pdf [firstpage_image] =>[orig_patent_app_number] => 10828795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675584 [patent_doc_number] => 20080213213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione' [patent_app_type] => utility [patent_app_number] => 11/547927 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24271 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213213.pdf [firstpage_image] =>[orig_patent_app_number] => 11547927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466830 [patent_doc_number] => 20040198771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation' [patent_app_type] => new [patent_app_number] => 10/823862 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16614 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198771.pdf [firstpage_image] =>[orig_patent_app_number] => 10823862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127912 [patent_doc_number] => 20050059656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Compositions and methods for protecting against mitochondria component-mediated pathology' [patent_app_type] => utility [patent_app_number] => 10/820184 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 280 [patent_figures_cnt] => 280 [patent_no_of_words] => 9961 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059656.pdf [firstpage_image] =>[orig_patent_app_number] => 10820184 [rel_patent_id] =>[rel_patent_doc_number] =>)